These FAQs outline key recommendations and practical takeaways from the 2026 AUA Medical Management of Kidney Stones guideline amendment.
|Articles|January 1, 2012
Percutaneous nephrolithotomy: Tricks and tips for access and stone removal
Listen
0:00 / 0:00
Key Takeaways
- Preoperative imaging is essential for surgical planning, providing detailed anatomical information that aids in precise execution and reduces complications.
- Selecting the optimal calyx for puncture is crucial for successful outcomes, influencing access, drainage, and potential complications.
Although percutaneous nephrolithotomy (PCNL) comprises only 4% to 6% of all stone surgeries, it behooves the urologist with an interest in stone disease to be facile in this treatment modality in order to offer patients the most appropriate and effective treatment for their stones.
Advertisement
Preoperative imaging
Selecting the optimal calyx for puncture
Advertisement
Related to this article
Jonathan Harper, MD, discusses findings from the PUSH trial may inform counseling on hydration and stone recurrence.
Positive safety and efficacy data from 4 clinical studies supported the CE marking.
Sandip Prasad, MD, discusses patient selection for chemoablation in recurrent LG-IR-NMIBC and considerations when counseling patients about a nonsurgical approach.
In a head-to-head RCT, Rezūm produced a 4.6-point greater IPSS improvement than combination pharmacotherapy at 1 year, according to Jean-Nicolas Cornu, MD, PhD, FEBU.
The AACU and the WOCN Society urge CMS to protect access to individualized catheter and ostomy supplies as competitive bidding begins in 2028.
Better detection has changed prostate cancer care. Patients choosing radical treatment still need better protection from the disease returning.
Enfortumab vedotin-ejfv (Padcev) plus pembrolizumab (Keytruda) showed the strongest EFS, OS, and PCR associations among neoadjuvant MIBC strategies in a network meta-analysis, although perioperative design limits attribution.
Advertisement
Advertisement
Trending on Urology Times
1
Evidence for Combining Prostatic Urethral Lift With Radiotherapy
2
After curative-intent treatment, prostate cancer recurrence is still an unmet need
3
Rezūm outperforms combination pharmacotherapy for BPH symptoms at 1 year
4
AACU, WOCN Society urge safeguards in Medicare catheter bidding
5